Psychiatry Investig.  2019 Jan;16(1):50-58. 10.30773/pi.2018.12.21.1.

Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018

Affiliations
  • 1Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. morezugli@gmail.com
  • 2Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.
  • 3Department of Clinical Neurosciences, Villa San Benedetto Menni, Hermanas Hospitalarias, FoRiPsi, Albese con Cassano, Italy.

Abstract


OBJECTIVE
Treatment for panic disorder (PD) have evolved, although there is still a strong unmet need for more effective and tolerable options. The present study summarizes and discusses recent evidence regarding the pharmacological and neuromodulatory treatment of PD.
METHODS
MEDLINE, Cochrane Library, PsycINFO and Thomson Reuters's Web of Science were searched for clinical trials published between 2010 and 2018. We included all prospective experimental studies including randomized controlled trials (RCT) and other clinical trials with more than 10 patients.
RESULTS
Only 11 articles met the inclusion criteria, including 4 RCT, 3 open clinical trials and 5 comparative clinical trials. RCT demonstrated efficacy of transcranial magnetic stimulation (TMS) in only one of two trials. Neither pindolol nor d-fenfluramine were effective in blocking flumazenil-induced panic attacks. Augmentation with quetiapine was not superior to placebo. Open trials indicated that escitalopram, vortioxetine and TMS may be effective. Comparative trials did not demonstrate superiority from any drug, but confirmed tranylcypromine, paroxetine, clonazepam and alprazolam as effective options.
CONCLUSION
The current study confirmed the efficacy of tranylcypromine, paroxetine, clonazepam, alprazolam and escitalopram. Vortioxetine and TMS, with duration of 4 or more weeks, also seems to be effective. Quetiapine, pindolol and d-fenfluramine were not considered effective compounds.

Keyword

Panic disorder; Transcranial magnetic stimulation; Treatment; Escitalopram; Vortioxetine

MeSH Terms

Alprazolam
Citalopram
Clonazepam
Humans
Panic Disorder*
Panic*
Paroxetine
Pindolol
Prospective Studies
Quetiapine Fumarate
Transcranial Magnetic Stimulation
Tranylcypromine
Alprazolam
Citalopram
Clonazepam
Paroxetine
Pindolol
Quetiapine Fumarate
Tranylcypromine
Full Text Links
  • PI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr